Loading...

China NT Pharma Group Company Limited

1011.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$0.42
HK$0.02(5.00%)

China NT Pharma Group Company Limited (1011.HK) Stock Overview

Explore China NT Pharma Group Company Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.4/100

Key Financials

Market Cap283.2M
P/E Ratio-1.90
EPS (TTM)$-0.22
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Week$0.47
1 Month$0.61
3 Months$0.06
1 Year Target$0.00

1011.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of China NT Pharma Group Company Limited (1011.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.90 and a market capitalization of 283.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

61.86RSI (14)
0.03MACD
51.99ADX
Stats data is not available for 1011.HKStats details for 1011.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for 1011.HKAnalyst Recommendations details for 1011.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.

CEO

Tit Ng

Employees

22

Headquarters

No. 1 Hua Ling Road, Suzhou

Founded

2011

Frequently Asked Questions

;